This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Aehr Test Systems (AEHR) Surges 9.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Aehr Test Systems (AEHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
AEHRNegative Net Change CAMTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Ero Copper (ERO): Can Its 9.0% Jump Turn into More Strength?
by Zacks Equity Research
Ero Copper (ERO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
EROPositive Net Change LEUNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Bumble (BMBL) Soars 25.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Bumble (BMBL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BMBLNegative Net Change ADPPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Adaptive Biotechnologies (ADPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ADPTNegative Net Change FTRENegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Ivanhoe Electric (IE) Moves 8.7% Higher: Will This Strength Last?
by Zacks Equity Research
Ivanhoe Electric (IE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
IEPositive Net Change AMRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
DLocal (DLO) Soars 8.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
DLocal (DLO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
DLOPositive Net Change NYAXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Cerence (CRNC) Moves 14.8% Higher: Will This Strength Last?
by Zacks Equity Research
Cerence (CRNC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CRNCPositive Net Change TLSNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Camtek (CAMT) Moves 9.0% Higher: Will This Strength Last?
by Zacks Equity Research
Camtek (CAMT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CAMTPositive Net Change INTTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Kamada (KMDA): Can Its 9.5% Jump Turn into More Strength?
by Zacks Equity Research
Kamada (KMDA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
KMDAPositive Net Change IMCRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Ocular Therapeutix (OCUL) Moves 8.6% Higher: Will This Strength Last?
by Zacks Equity Research
Ocular Therapeutix (OCUL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
OCULNegative Net Change TAKPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Peakstone Realty Trust (PKST) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PKSTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
STMicroelectronics (STM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
STMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy ASML (ASML) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ASMLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Strength Seen in Krystal Biotech (KRYS): Can Its 4.2% Jump Turn into More Strength?
by Zacks Equity Research
Krystal Biotech (KRYS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
KRYSPositive Net Change CHRSNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Redwire Corporation (RDW) Surges 7.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Redwire Corporation (RDW) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RDWNegative Net Change NOCNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Veeva Systems (VEEV) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
VEEVPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Amarin (AMRN) Soars 27.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Amarin (AMRN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
AMRNNegative Net Change MNKDPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Capricor (CAPR) Moves 20.4% Higher: Will This Strength Last?
by Zacks Equity Research
Capricor (CAPR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
CAPRPositive Net Change MYOPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength?
by Zacks Equity Research
Outset Medical (OM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
OMNegative Net Change SENSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Grupo Cibest (CIB) Moves 5.5% Higher: Will This Strength Last?
by Zacks Equity Research
Grupo Cibest (CIB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CIBPositive Net Change KBCSYPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Nu (NU): Can Its 8.8% Jump Turn into More Strength?
by Zacks Equity Research
Nu (NU) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
NUNegative Net Change BCHPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last?
by Zacks Equity Research
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
TDOCPositive Net Change BSXPositive Net Change GGGNegative Net Change STEMPositive Net Change CGENPositive Net Change MODPositive Net Change FWONANegative Net Change STROPositive Net Change PGNYNegative Net Change LFMDPositive Net Change TTEPositive Net Change INDVNegative Net Change RNACNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains?
by Zacks Equity Research
Exelixis (EXEL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
EXELPositive Net Change BSXPositive Net Change GGGNegative Net Change STEMPositive Net Change CGENPositive Net Change STROPositive Net Change PGNYNegative Net Change RNACNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Nektar (NKTR): Can Its 12.1% Jump Turn into More Strength?
by Zacks Equity Research
Nektar (NKTR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
NKTRPositive Net Change BSXPositive Net Change GGGNegative Net Change STEMPositive Net Change CGENPositive Net Change MODPositive Net Change FWONANegative Net Change STROPositive Net Change PGNYNegative Net Change INDVNegative Net Change RNACNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
XOMA Royalty (XOMA) Moves 9.0% Higher: Will This Strength Last?
by Zacks Equity Research
XOMA Royalty (XOMA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
XOMAPositive Net Change CGENPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today